BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

  April 16, 2025

   · 

  8 min read
• Press Releases

  Biocon Biologics Secures Market Entry Date for Yesafili™, an Interchangeable Biosimilar to Eylea®, in the U.S.

  April 16, 2025

   · 

  7 min read
• Press Releases

  Fortrea Announces Date for First Quarter 2025 Financial Results and Conference Call

  April 16, 2025

   · 

  1 min read
• Press Releases

  Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting

  April 16, 2025

   · 

  3 min read
• Press Releases

  Vistin Pharma ASA: Invitation to Q1 2025 conference call

  April 16, 2025

   · 

  1 min read
• Press Releases

  Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

  April 16, 2025

   · 

  4 min read
• Press Releases

  Remix Therapeutics Appoints Linda C. Bain to Board of Directors

  April 16, 2025

   · 

  2 min read
• Press Releases

  Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

  April 16, 2025

   · 

  10 min read
• Press Releases

  Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis

  April 16, 2025

   · 

  4 min read
• Press Releases

  Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments

  April 16, 2025

   · 

  7 min read